1663
Among the risk factors studied, two appear to increase the risk of ARE: the prescription of thiabendazole to treat strongyloidiasis during the melarsoprol cure and the bad general clinical conditions of patients.
 increase the risk of ARE: Effect; prescription of thiabendazole: Treatment; during the melarsoprol cure: Treatment; thiabendazole: Treatment.Drug; melarsoprol: Treatment.Drug; strongyloidiasis: Treatment.Disorder
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 increase the risk of ARE: Effect; prescription of thiabendazole: Treatment; during the melarsoprol cure: Treatment; thiabendazole: Treatment.Drug; melarsoprol: Treatment.Drug; strongyloidiasis: Treatment.Disorder